Cost Effectiveness Evaluation Of Apixaban, Dabigatran Rivaroxaban And Warfarin For Prevention Of Tromboembolism In Patients With Atrial Fibrillation In Trinidad And Tobago
Abstract
Authors
M. Garita M. Peralta T.A. Dookie
M. Garita M. Peralta T.A. Dookie
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now